PT73666B - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
PT73666B
PT73666B PT73666A PT7366681A PT73666B PT 73666 B PT73666 B PT 73666B PT 73666 A PT73666 A PT 73666A PT 7366681 A PT7366681 A PT 7366681A PT 73666 B PT73666 B PT 73666B
Authority
PT
Portugal
Prior art keywords
therapeutic agents
therapeutic
agents
Prior art date
Application number
PT73666A
Other languages
English (en)
Other versions
PT73666A (en
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of PT73666A publication Critical patent/PT73666A/pt
Publication of PT73666B publication Critical patent/PT73666B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/233Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/24Oxygen atoms attached in position 8
    • C07D215/26Alcohols; Ethers thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
PT73666A 1980-09-26 1981-09-14 Therapeutic agents PT73666B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8031106 1980-09-26
GB8031162 1980-09-26
GB8118879 1981-06-19
GB8119062 1981-06-19

Publications (2)

Publication Number Publication Date
PT73666A PT73666A (en) 1981-10-01
PT73666B true PT73666B (en) 1982-11-22

Family

ID=27449208

Family Applications (1)

Application Number Title Priority Date Filing Date
PT73666A PT73666B (en) 1980-09-26 1981-09-14 Therapeutic agents

Country Status (25)

Country Link
US (2) US4442109A (pt)
AT (1) AT379388B (pt)
AU (1) AU549078B2 (pt)
BG (2) BG36495A3 (pt)
CA (1) CA1146943A (pt)
CH (1) CH650254A5 (pt)
DD (1) DD201890A5 (pt)
DE (1) DE3138121A1 (pt)
DK (1) DK152674C (pt)
ES (2) ES505786A0 (pt)
FI (1) FI812997L (pt)
FR (1) FR2491064A1 (pt)
GR (1) GR75797B (pt)
IE (1) IE51542B1 (pt)
IL (1) IL63845A (pt)
IT (1) IT1189449B (pt)
LU (1) LU83649A1 (pt)
NL (1) NL8104394A (pt)
NO (1) NO154052C (pt)
NZ (1) NZ198414A (pt)
PH (1) PH18605A (pt)
PT (1) PT73666B (pt)
RO (2) RO82014A (pt)
SE (1) SE457533B (pt)
YU (2) YU230181A (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT79031B (en) * 1983-08-20 1986-08-22 Boots Co Plc Therapeutic agents
EP0149519B1 (en) * 1984-01-13 1990-06-27 The Boots Company PLC Use of quinolones for the manufacture of a composition for the treatment of heart failure.
EP0172004B1 (en) * 1984-08-15 1990-03-21 The Boots Company PLC Quinolinones, process for their preparation and pharmaceutical compositions containing them
GB8515209D0 (en) * 1985-06-15 1985-07-17 Boots Co Plc Therapeutic agents
GB8515207D0 (en) * 1985-06-15 1985-07-17 Boots Co Plc Therapeutic agents
GB8627698D0 (en) * 1986-11-20 1986-12-17 Boots Co Plc Therapeutic agents
GB8726950D0 (en) * 1987-11-18 1987-12-23 Boots Co Plc Chemical process
GB8804016D0 (en) * 1988-02-22 1988-03-23 Boots Co Plc Therapeutic agents

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121725A (en) * 1960-07-18 1964-02-18 Phillips Petroleum Co N-heterocyclic sulfides, sulfoxides, sulfones, and n-oxides of said sulfoxides and sulfones
US3801644A (en) * 1971-08-25 1974-04-02 Warner Lambert Co Substituted-o-hydroxy-omega-(methylsulfinyl)acetophenones and process for producing same
US3772301A (en) * 1971-11-22 1973-11-13 Warner Lambert Co (4-substituted)4-(methylsulfinyl)methylcarbostyrils
US4343805A (en) * 1978-12-16 1982-08-10 John Wyeth & Brother Limited Heterocyclic compounds
GB2038825B (en) * 1978-12-16 1983-02-09 Wyeth John & Brother Ltd Heterocyclic compounds substituted by heterocyclyl-alkyl-thio groups
ZA801575B (en) * 1979-03-27 1981-03-25 Boots Co Ltd Therapeutic agents
NZ193167A (en) * 1979-03-27 1984-08-24 Boots Co Plc Quinoline derivatives and pharmaceutical compositions
US4302360A (en) * 1980-01-11 1981-11-24 Agency Of Industrial Science & Technology Catalyst for catalytic combustion of hydrogen

Also Published As

Publication number Publication date
RO82014B (ro) 1983-05-30
DK152674C (da) 1988-08-22
IE51542B1 (en) 1987-01-07
SE457533B (sv) 1989-01-09
RO85318A (ro) 1984-09-29
IE812033L (en) 1982-03-02
FR2491064B1 (pt) 1984-03-16
RO82014A (ro) 1983-06-01
FR2491064A1 (fr) 1982-04-02
BG36495A3 (en) 1984-11-15
DK424781A (da) 1982-03-27
ES8302662A1 (es) 1982-12-01
ATA412181A (de) 1985-05-15
IT1189449B (it) 1988-02-04
BG36344A3 (en) 1984-10-15
AT379388B (de) 1985-12-27
SE8105689L (sv) 1982-03-27
CA1146943A (en) 1983-05-24
NL8104394A (nl) 1982-04-16
IL63845A0 (en) 1981-12-31
YU230181A (en) 1983-12-31
GR75797B (pt) 1984-08-02
YU144683A (en) 1983-12-31
NO813263L (no) 1982-03-29
ES514411A0 (es) 1983-05-01
NO154052C (no) 1986-07-16
DD201890A5 (de) 1983-08-17
AU7552481A (en) 1982-04-01
US4447435A (en) 1984-05-08
US4442109A (en) 1984-04-10
DK152674B (da) 1988-04-11
CH650254A5 (fr) 1985-07-15
RO85318B (ro) 1984-10-30
IL63845A (en) 1985-02-28
IT8149370A0 (it) 1981-09-25
NZ198414A (en) 1983-11-18
ES8306111A1 (es) 1983-05-01
LU83649A1 (fr) 1983-02-22
ES505786A0 (es) 1982-12-01
NO154052B (no) 1986-04-01
PH18605A (en) 1985-08-21
PT73666A (en) 1981-10-01
FI812997L (fi) 1982-03-27
AU549078B2 (en) 1986-01-16
DE3138121A1 (de) 1982-04-15

Similar Documents

Publication Publication Date Title
GB2098602B (en) Therapeutic agents
ZM2482A1 (en) Therapeutic agents
ZA818665B (en) Therapeutic agents
DE3165786D1 (en) Imidazolylpyridine therapeutic agents
ZA828453B (en) Therapeutic agents
EG16991A (en) Therapeutic agents
ZA81715B (en) Antirhinovirus agents
PT73666A (en) Therapeutic agents
GB2085441B (en) Therapeutic agents
EP0051789A3 (en) Therapeutic composition
JPS56130153A (en) Massager
ZA836848B (en) Therapeutic agents
JPS56125047A (en) Massager
JPS56104661A (en) Massager
JPS5717655A (en) Massager
ZA816352B (en) Therapeutic agents
JPS56125054A (en) Massager
JPS56125046A (en) Massager
JPS57112868A (en) Massager
JPS56152649A (en) Massager
ZW22481A1 (en) Therapeutic agents
JPS56151048A (en) Massager
JPS56125052A (en) Massager
IE801360L (en) Therapeutic combinations
GB8326222D0 (en) Therapeutic agents